Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Togashi

Showing results (61-70 of 156) with videos related to

Pageof 16
Sort By:
Cancer Science|June 20, 2024
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse modelKazuhiro Okumura, Takao Morinaga, Megumi Saito, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2026
Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancerRyo Yoshichika, Fumiaki Mukohara, Kotaro Yamada, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2010
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancerKatsuhiro Masago, Shiro Fujita, Young Hak Kim, et al.
Oncology Letters|August 7, 2012
Association between brain natriuretic peptide and distant metastases in advanced non-small cell lung cancer patientsKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
Oncology Letters|September 12, 2012
Infectious background of febrile advanced lung cancer patients who received chemotherapyKatsuhiro Masago, Akiko Fukuhara, Yutaka Ito, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2012
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancerYosuke Togashi, Katsuhiro Masago, Satohiro Masuda, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2011
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.
Oncology Reports|August 2, 2011
Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancerKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
The Journal of Experimental Medicine|September 21, 2019
Selective inhibition of low-affinity memory CD8<sup>+</sup> T cells by corticosteroidsAkihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2010
Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancerYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.
Pageof 16

Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
Cancer Science|June 20, 2024
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse modelKazuhiro Okumura, Takao Morinaga, Megumi Saito, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2026
Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancerRyo Yoshichika, Fumiaki Mukohara, Kotaro Yamada, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2010
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancerKatsuhiro Masago, Shiro Fujita, Young Hak Kim, et al.
Oncology Letters|August 7, 2012
Association between brain natriuretic peptide and distant metastases in advanced non-small cell lung cancer patientsKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
Oncology Letters|September 12, 2012
Infectious background of febrile advanced lung cancer patients who received chemotherapyKatsuhiro Masago, Akiko Fukuhara, Yutaka Ito, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2012
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancerYosuke Togashi, Katsuhiro Masago, Satohiro Masuda, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2011
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.
Oncology Reports|August 2, 2011
Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancerKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
The Journal of Experimental Medicine|September 21, 2019
Selective inhibition of low-affinity memory CD8<sup>+</sup> T cells by corticosteroidsAkihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2010
Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancerYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.
Pageof 16